High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Andriatahina, Todisoa ^a   Randrianirina, Frédérique ^b   Hariniana, Eliosa R ^b   Talarmin, Antoine ^b   Raobijaona, Honoré ^a   Buisson, Yves ^c   Richard, Vincent ^b  

^a Cenire Hosp Univ Befelatanana   (Madagascar)

^b INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^c Institut de la Francophonie pour la Medecine Tropicale   (Laos)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MADAGASCAR; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; NONHUMAN; PEDIATRICS; PREVALENCE; RECTAL SWAB; RISK FACTOR; SMEAR; BIOSYNTHESIS; CHILD; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; FECES; HEALTH CARE PERSONNEL; HETEROZYGOTE; HOSPITAL; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEWBORN; PRESCHOOL CHILD;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIRONMENTAL MICROBIOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HEALTH PERSONNEL; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MADAGASCAR; MALE; PREVALENCE;

EID: 77954401562     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-204     Document Type: Article

References (31)

1. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-51. 10.1128/CMR.14.4.933-951.2001, 89009, 11585791.
2. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995, 8:557-584. 172876, 8665470.
3. Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
4. Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G. Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 2003, 9:1024-1025.
5. Paterson DL, Yu VL. Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis 1999, 29:1419-1422. 10.1086/313559, 10585789.
6. Castillo Garcia FJ, Seral Garcia C, Pardos De la Gandara M, Millan Lou MI, Pitart Ferre C. Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods. Eur J Clin Microbiol Infect Dis 2007, 26:77-78. 10.1007/s10096-006-0242-8, 17180346.
7. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004, 101:3709-3714. 10.1073/pnas.0400456101, 373527, 14985511.
8. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DSM, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 2005, 43:745-749. 10.1128/JCM.43.2.745-749.2005, 548071, 15695674.
9. Sehgal R, Gaind R, Chellani H, Agarwal P. Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. Ann Trop Paediatr 2007, 27:45-54. 10.1179/146532807X170501, 17469732.
10. Randrianirina F, Soares J, Carod J, Ratsima E, Thonnier V, Combe P, Grosjean P, Talarmin A. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother 2007, 59:309-312. 10.1093/jac/dkl466, 17138569.
11. Randrianirina F, Vaillant L, Ramarokoto C, Rakotoarijaona A, Andriamanarivo M, Razafimahandry H, Randrianomenjanahary J, Raveloson J, Ratsima Hariniaina E, Carod JF, Talarmin A, Richard V. Antimicrobial resistance in pathogens causing nosocomial infections in surgery and intensive care wards of two hospitals in Antananarivo, Madagascar. JIDC 2010, 4(2):74-82.
12. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
13. Osterblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O, Huovinen P, Kotilainen P. A between-species comparison of antimicrobial resistance in Enterobacteria in fecal flora. Antimicrob Agents Chemother 2000, 44:1479-1484. 10.1128/AAC.44.6.1479-1484.2000, 89900, 10817696.
14. Brinas L, Zarazaga M, Saenz Y, Ruiz-Larrea F, Torres C. Beta-lactamases in ampicillin-resistant Escherichia Coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 2002, 46:3156-3163. 10.1128/AAC.46.10.3156-3163.2002, 128764, 12234838.
15. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Ariza J, Gudiol F. Epidemiology and successful control of a large outbreak due to Klebsiella Pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998, 42:53-58. 105455, 9449260.
16. Hollander R, Ebke M, Barck H, von Pritzbuer E. Asymptomatic carriage of Klebsiella Pneumoniae producing extended-spectrum beta-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J Hosp Infect 2001, 48:207-213. 10.1053/jhin.2001.0997, 11439008.
17. De Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R, Baguet JC, Sirot J. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989, 27:2887-2890. 267156, 2592552.
18. Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004, 42:4769-4775. 10.1128/JCM.42.10.4769-4775.2004, 522353, 15472339.
19. Moubareck C, Daoud Z, Hakime NI, Hamze M, Mangeney N, Matta H, Mokhbat JE, Rohban R, Sarkis DK, Doucet-Populaire F. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (ctx-m-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol 2005, 43:3309-3313. 10.1128/JCM.43.7.3309-3313.2005, 1169093, 16000453.
20. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia Coli and Klebsiella Pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007, 28:1114-1116. 10.1086/519865, 17932839.
21. Demir S, Soysal A, Bakir M, Kaufmann ME, Yagci A. Extended-spectrum beta-lactamase-producing Klebsiella Pneumoniae in paediatric wards: a nested case-control study. J Paediatr Child Health 2008, 44:548-553. 10.1111/j.1440-1754.2008.01326.x, 18557808.
22. Harris AD, Nemoy L, Johnson JA, Martin-Carnahan A, Smith DL, Standiford H, Perencevich EN. Co-carriage rates of vancomycin-resistant enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004, 25:105-108. 10.1086/502358, 14994933.
23. Singh N, Patel KM, Leger M, Short B, Sprague BM, Kalu N, Campos JM. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 2002, 21:1029-1033. 10.1097/00006454-200211000-00010, 12442024.
24. Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001, 33(Suppl 3):S161-9. 10.1086/321843, 11524714.
25. Canton R, Coque TM, Baquero F. Multi-resistant gram-negative bacilli: from epidemics to endemics. Curr Opin Infect Dis 2003, 16:315-325.
26. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002, 8:347-354. 10.3201/eid0804.010312, 2730242, 11971765.
27. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, Weinstein RA. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158:1127-1132. 10.1001/archinte.158.10.1127, 9605785.
28. Green M, Barbadora K. Recovery of ceftazidime-resistant Klebsiella Pneumoniae from pediatric liver and intestinal transplant recipients. Pediatr Transplant 1998, 2:224-230.
29. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia Coli in nursing homes. JAMA 1999, 281:517-523. 10.1001/jama.281.6.517, 10022107.
30. Trick WE, Weinstein RA, DeMarais PL, Kuehnert MJ, Tomaska W, Nathan C, Rice TW, McAllister SK, Carson LA, Jarvis WR. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001, 49:270-276. 10.1046/j.1532-5415.2001.4930270.x, 11300237.
31. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia Coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094. 10.1128/JCM.42.3.1089-1094.2004, 356843, 15004058.